📰 Alkermes News
Page 43 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
March 29, 2023
Niraparib maintenance does not improve overall survival in patients with platinum-sensitive recurrent ovarian cancer, updated data suggest.
March 28, 2023
StockNews.com upgraded shares of Alkermes (NASDAQ:ALKS – Get Rating) from a buy rating to a strong-buy rating in a research report report published on Friday morning. A number of other brokerages also recently issued reports on ALKS. HC Wainwright reaffirmed a neutral rating and set a $32.00 price target on shares of Alkermes in a […]
March 28, 2023
Niraparib did not significantly extend OS among women with recurrent ovarian cancer, according to long-term follow-up results of the ENGOT-OV16/NOVA trial presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer. A previously presented analysis of OS, a secondary endpoint of the trial, had been limited due to missing follow-up data on survival status and
March 27, 2023
Shares of Alkermes plc (NASDAQ:ALKS – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation […]
March 25, 2023
Alkermes was recently named to Ragan Communications and PR Daily’ list of Top Places to Work for 2023!
March 16, 2023
/PRNewswire/ -- The ERP Biomarker Qualification Consortium announced today the publication of all data (https://doi.org/10.1016/j.schres.2023.02.018) from a...
March 15, 2023
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the Stifel 2023 CNS Days on...
March 14, 2023
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a...
March 13, 2023
Author summary Why was this study done? Patients with severe mental illness (SMI) have been reported to have excess mortality from sepsis (number of deaths due to sepsis in the whole population). Whether SMI is associated with higher or lower sepsis-associated case fatality remains unclear (number of deaths due to sepsis in the population with sepsis). No study has determined whether SMI is associated with excess case fatality in patients with septic shock, the most severe form of sepsis when ...
March 12, 2023
Operator: Welcome to the Acorda Therapeutics Fourth Quarter and Year-End 2022 Financial and Business Update. Please be advised that this call is being recorded at the companys request.